-VISIT OUR OTHER FORUMS- OB-GYN-L Ultrasound Ultrasound History Fibroid Forum Physicians-in-Training Tech Talk OBSTET-L (portuguese) OBGIN-L (spanish) Nursing

Re: Bromocriptine and pregnancy From: art fougner, md (evsono@pipeline.com) Wed Sep 21 10:56:09 2005 Messages sorted by: [ date ][ thread ][ subject ][ author ] Next message: Atkinson, Samuel M: "Re: Bromocriptine and pregnancy" Previous message: mjutras@gate.net: "Re: Bromocriptine and pregnancy" In reply to: Elrod Darryl G MAJ 48 MDOS/SGOBO: "Bromocriptine and pregnancy" Next in thread: Robert J. Carpenter, Jr. MD: "Re: Bromocriptine and pregnancy" Reply: Robert J. Carpenter, Jr. MD: "Re: Bromocriptine and pregnancy" >From Creasy & Resnick 4th ed ... Management of Patients harboring prolactinomas during gestation Microadenoma - asymptomatic patient - STOP bromocryptine Routine OB care with evaluation for symptoms of tumor expansion visual fields per trimester symptomatic patient - check visual fields serum prolactin MRI initiate bromocryptine w or w/o dexamthasone for visual complications surgery if unresponsive to medical therapy Macroadenoma - asymptomatic - STOP bromocryptine Monthly evaluation for symptoms of tumor expansion Monthly visual fields symptomatic - as for Microadenoma hope this helps art At Wed, 21 Sep 2005, Elrod Darryl G MAJ 48 MDOS/SGOBO wrote: > >I'm getting conflicting recommendations regarding the continued use of >bromocriptine once someone becomes pregnant. Up to Date says to stop it >once pregnancy is confirmed and Williams doesn't really say, but says >that 6000 women have taken it without adverse affects to the pregnancy. > >Does anyone have any better guidelines than these? > >Thanks, > >Glen > >//SIGNED// > >D. Glen Elrod, Maj., USAF, MC > >Obstetrician/Gynecologist > >Chief of Obstetrics > >48 MDOS/SGOBO > >RAF Lakenheath, England > >Telephone DSN: 314-226-8130 > > Comm: +44 (0) 1638 52 8130 > >Notice of Confidentiality >Under the Privacy Act of 1974, you must safeguard all information >reflected on this e-mail and, if applicable, all attachments. >Disclosure of information is IAW AFI 33-119, AFI 33-127, AFI 37-131, AFI >37-132, AFI 33-219, and PL 93-579" >This e-mail message including any attachments is for the sole use of the >intended recipient(s) and may contain confidential and privileged >information. Any unauthorized review, use, disclosure or distribution is >prohibited. If you are not the intended recipient, please contact the >sender by reply e-mail and destroy all copies of the original message. >Any questions pertaining to disclosure should be directed to the privacy >officer. -- art fougner, md "If you don't know where you are going, you will wind up somewhere else." Lawrence Peter Berra Next message: Atkinson, Samuel M: "Re: Bromocriptine and pregnancy" Previous message: mjutras@gate.net: "Re: Bromocriptine and pregnancy" In reply to: Elrod Darryl G MAJ 48 MDOS/SGOBO: "Bromocriptine and pregnancy" Next in thread: Robert J. Carpenter, Jr. MD: "Re: Bromocriptine and pregnancy" Reply: Robert J. Carpenter, Jr. MD: "Re: Bromocriptine and pregnancy"

Return to

Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Sun Nov 2 04:52:46 2008

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.